Spotlight on Geminin

Breast Cancer Research

Volumn 13, Issue 3, 2011, Pages

  DePamphilis, Melvin L ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GEMININ; CHECKPOINT KINASE 1; DNA TOPOISOMERASE (ATP HYDROLYSING); HISTONE H2AX; CDC7 PROTEIN, HUMAN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; DNA TOPOISOMERASE II ALPHA; GMNN PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; TUMOR ANTIGEN;

DNA REPLICATION; DRUG MECHANISM; EDITORIAL; GENE DUPLICATION; GENOME; HUMAN; NONHUMAN; SISTER CHROMATID; CANCER DIAGNOSIS; CANCER PROGNOSIS; CELL DIVISION; CELL FATE; ENZYME INHIBITION; GENE EXPRESSION; GENOMIC INSTABILITY; PREDICTIVE VALUE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; ANEUPLOIDY; BIOSYNTHESIS; BREAST; FEMALE; HUMAN CHROMOSOME; METABOLISM; NOTE;

ANEUPLOIDY; ANTIGENS, NEOPLASM; BREAST; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; FEMALE; HUMANS; PROTEIN-SERINE-THREONINE KINASES;

EID: 84860395266     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2881     Document Type: Editorial

References (16)

1. Gardner L, Malik R, Shimizu Y, Mullins N, ElShamy WM. Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation leading to aneuploidy in human mammary epithelial cells. Breast Cancer Res 2011, 13:R53. 10.1186/bcr2884, 21595939.
2. DePamphilis ML. DNA Replication and Human Disease 2006, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
3. Lim JW, Hummert P, Mills JC, Kroll KL. Geminin cooperates with Polycomb to restrain multi-lineage commitment in the early embryo. Development 2011, 138:33-44. 10.1242/dev.059824, 21098561.
4. Yellajoshyula D, Patterson ES, Elitt MS, Kroll KL. Geminin promotes neural fate acquisition of embryonic stem cells by maintaining chromatin in an accessible and hyperacetylated state. Proc Natl Acad Sci USA 2011, 108:3294-3299. 10.1073/pnas.1012053108, 21300881.
5. Miotto B, Struhl K. HBO1 histone acetylase activity is essential for DNA replication licensing and inhibited by Geminin. Mol Cell 2010, 37:57-66. 10.1016/j.molcel.2009.12.012, 2818871, 20129055.
6. Falaschi A, Abdurashidova G, Biamonti G. DNA replication, development and cancer: a homeotic connection?. Crit Rev Biochem Mol Biol 2010, 45:14-22. 10.3109/10409230903365608, 19919294.
7. Lutzmann M, Mechali M. MCM9 binds Cdt1 and is required for the assembly of prereplication complexes. Mol Cell 2008, 31:190-200. 10.1016/j.molcel.2008.07.001, 18657502.
8. Haruki T, Shomori K, Hamamoto Y, Taniguchi Y, Nakamura H, Ito H. Geminin expression in small lung adenocarcinomas: implication of prognostic significance. Lung Cancer 2011, 71:356-362. 10.1016/j.lungcan.2010.06.013, 20650542.
9. Zhu W, Depamphilis ML. Selective killing of cancer cells by suppression of geminin activity. Cancer Res 2009, 69:4870-4877. 10.1158/0008-5472.CAN-08-4559, 2749580, 19487297.
10. Lee J, Kim JA, Margolis RL, Fotedar R. Substrate degradation by the anaphase promoting complex occurs during mitotic slippage. Cell Cycle 2010, 9:1792-1801. 10.4161/cc.9.9.11519, 20436289.
11. Nakuci E, Xu M, Pujana MA, Valls J, Elshamy WM. Geminin is bound to chromatin in G2/M phase to promote proper cytokinesis. Int J Biochem Cell Biol 2006, 38:1207-1220. 10.1016/j.biocel.2005.12.017, 16487741.
12. Schultz KM, Banisadr G, Lastra RO, McGuire T, Kessler JA, Miller RJ, McGarry TJ. Geminin-deficient neural stem cells exhibit normal cell division and normal neurogenesis. PLoS One 2011, 6:e17736. 10.1371/journal.pone.0017736, 3052383, 21408022.
13. Shinnick KM, Eklund EA, McGarry TJ. Geminin deletion from hematopoietic cells causes anemia and thrombocytosis in mice. J Clin Invest 2010, 120:4303-4315. 10.1172/JCI43556, 2993593, 21041951.
14. Shreeram S, Sparks A, Lane DP, Blow JJ. Cell type-specific responses of human cells to inhibition of replication licensing. Oncogene 2002, 21:6624-6632. 10.1038/sj.onc.1205910, 12242660.
15. Blow JJ, Gillespie PJ. Replication licensing and cancer - a fatal entanglement?. Nat Rev Cancer 2008, 8:799-806. 10.1038/nrc2500, 2577763, 18756287.
16. Nevis KR, Cordeiro-Stone M, Cook JG. Origin licensing and p53 status regulate Cdk2 activity during G(1). Cell Cycle 2009, 8:1952-1963. 10.4161/cc.8.12.8811, 2972510, 19440053.